Benclonidine

This classification denotes an antihypertensive agent with the molecular formula C16H13Cl2N3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1999398A3P, chemically known as 4,5-dihydro-1-benzoyl-n-(2,6-dichlorophenyl)-1h-imidazol-2-amine but generally known as benclonidine, which bears US NIH Compound Identifier 68774. European Medicines Agency schedules Benclonidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05704MIG. The term BENCLONIDINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 34, No. 10 1980, List 20). BENCLONIDINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule benclonidine under HS 29332990 and SITC 51573. As of Q4 2014, BENCLONIDINE remains the US FDA Preferred Term for this commodity. Benclonidine bears US NLM identifiers UMLS ID C2346992 and NCI Concept Code C72972. SMILES: Clc1c(NC2=NCCN2C(=O)c2ccccc2)c(Cl)ccc1.